In July, the Duke Neurology Department published ten new studies spanning a wide range of topics. Even after controlling for individual characteristics, a study discovered a link between poor socioeconomic situations and poor outcomes for critically ill patients. Researchers gained new insights into the cellular evolution of ALS and assessed the potential off-label usage of Nuedexta for ALS symptoms. Other studies shed light on Parkinson’s symptoms, Behcet’s disease complications, stroke treatments, and proteome changes associated with Alzheimer’s disease. Researchers also looked into the significance of immunological pathways in learning and memory, as well as the effect of functional brain networks on cognitive function as people age. Finally, Duke researchers created an enhanced mouse model that included human APOE and TOMM40 genes.

To know more: About the original article click here.